_version_ 1783649350273990656
author Maiti, Abhishek
DiNardo, Courtney D.
Daver, Naval G.
Rausch, Caitlin R.
Ravandi, Farhad
Kadia, Tapan M.
Pemmaraju, Naveen
Borthakur, Gautam
Bose, Prithviraj
Issa, Ghayas C.
Short, Nicholas J.
Yilmaz, Musa
Montalban-Bravo, Guillermo
Ferrajoli, Alessandra
Jabbour, Elias J.
Jain, Nitin
Ohanian, Maro
Takahashi, Koichi
Thompson, Philip A.
Loghavi, Sanam
Montalbano, Kathryn S.
Pierce, Sherry
Wierda, William G.
Kantarjian, Hagop M.
Konopleva, Marina Y.
author_facet Maiti, Abhishek
DiNardo, Courtney D.
Daver, Naval G.
Rausch, Caitlin R.
Ravandi, Farhad
Kadia, Tapan M.
Pemmaraju, Naveen
Borthakur, Gautam
Bose, Prithviraj
Issa, Ghayas C.
Short, Nicholas J.
Yilmaz, Musa
Montalban-Bravo, Guillermo
Ferrajoli, Alessandra
Jabbour, Elias J.
Jain, Nitin
Ohanian, Maro
Takahashi, Koichi
Thompson, Philip A.
Loghavi, Sanam
Montalbano, Kathryn S.
Pierce, Sherry
Wierda, William G.
Kantarjian, Hagop M.
Konopleva, Marina Y.
author_sort Maiti, Abhishek
collection PubMed
description
format Online
Article
Text
id pubmed-7873265
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78732652021-02-18 Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia Maiti, Abhishek DiNardo, Courtney D. Daver, Naval G. Rausch, Caitlin R. Ravandi, Farhad Kadia, Tapan M. Pemmaraju, Naveen Borthakur, Gautam Bose, Prithviraj Issa, Ghayas C. Short, Nicholas J. Yilmaz, Musa Montalban-Bravo, Guillermo Ferrajoli, Alessandra Jabbour, Elias J. Jain, Nitin Ohanian, Maro Takahashi, Koichi Thompson, Philip A. Loghavi, Sanam Montalbano, Kathryn S. Pierce, Sherry Wierda, William G. Kantarjian, Hagop M. Konopleva, Marina Y. Blood Cancer J Correspondence Nature Publishing Group UK 2021-02-01 /pmc/articles/PMC7873265/ /pubmed/33563904 http://dx.doi.org/10.1038/s41408-021-00410-w Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Maiti, Abhishek
DiNardo, Courtney D.
Daver, Naval G.
Rausch, Caitlin R.
Ravandi, Farhad
Kadia, Tapan M.
Pemmaraju, Naveen
Borthakur, Gautam
Bose, Prithviraj
Issa, Ghayas C.
Short, Nicholas J.
Yilmaz, Musa
Montalban-Bravo, Guillermo
Ferrajoli, Alessandra
Jabbour, Elias J.
Jain, Nitin
Ohanian, Maro
Takahashi, Koichi
Thompson, Philip A.
Loghavi, Sanam
Montalbano, Kathryn S.
Pierce, Sherry
Wierda, William G.
Kantarjian, Hagop M.
Konopleva, Marina Y.
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
title Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
title_full Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
title_fullStr Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
title_full_unstemmed Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
title_short Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
title_sort triplet therapy with venetoclax, flt3 inhibitor and decitabine for flt3-mutated acute myeloid leukemia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873265/
https://www.ncbi.nlm.nih.gov/pubmed/33563904
http://dx.doi.org/10.1038/s41408-021-00410-w
work_keys_str_mv AT maitiabhishek triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT dinardocourtneyd triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT davernavalg triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT rauschcaitlinr triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT ravandifarhad triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT kadiatapanm triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT pemmarajunaveen triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT borthakurgautam triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT boseprithviraj triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT issaghayasc triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT shortnicholasj triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT yilmazmusa triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT montalbanbravoguillermo triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT ferrajolialessandra triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT jabboureliasj triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT jainnitin triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT ohanianmaro triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT takahashikoichi triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT thompsonphilipa triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT loghavisanam triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT montalbanokathryns triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT piercesherry triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT wierdawilliamg triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT kantarjianhagopm triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia
AT konoplevamarinay triplettherapywithvenetoclaxflt3inhibitoranddecitabineforflt3mutatedacutemyeloidleukemia